89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 158 filers reported holding 89BIO INC in Q2 2023. The put-call ratio across all filers is 2.37 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,416,948 | $216,351,165 | 4.08% |
| Orchard Capital Management, LLC | 542,879 | $10,287,557 | 3.46% |
| Artia Global Partners LP | 465,465 | $8,820,562 | 3.04% |
| Octagon Capital Advisors LP | 1,066,784 | $20,215,557 | 2.81% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,393,236 | $45,351,822 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 396,497 | $7,513,618 | 2.32% |
| Boxer Capital, LLC | 2,100,000 | $39,795 | 1.85% |
| Velan Capital Investment Management LP | 95,000 | $1,800,250 | 1.67% |
| Cormorant Asset Management, LP | 1,350,000 | $25,582,500 | 1.43% |
| Tri Locum Partners LP | 165,897 | $3,143,748 | 1.17% |
| Parkman Healthcare Partners LLC | 348,875 | $6,611,181 | 1.15% |
| BVF INC/IL | 1,846,154 | $34,984,618 | 0.98% |
| Newtyn Management, LLC | 200,000 | $3,790,000 | 0.90% |
| 1492 Capital Management LLC | 78,404 | $1,485,755 | 0.86% |
| EAM Investors, LLC | 216,438 | $4,101,500 | 0.76% |
| Redmile Group, LLC | 761,955 | $14,439,047 | 0.55% |
| Endurant Capital Management LP | 29,282 | $554,894 | 0.48% |
| Soleus Capital Management, L.P. | 226,500 | $4,292,175 | 0.48% |
| Deep Track Capital, LP | 503,100 | $9,533,745 | 0.44% |
| SPHERA FUNDS MANAGEMENT LTD. | 135,000 | $2,558,250 | 0.40% |
External links
This page lists 89BIO INC's shareholders in Q2 2023. To view 89BIO INC's shareholder history, click here.